Moderna's Q1 revenue beats and guidance

Statements (8)

1. ● Neutral

   Moderna is turning a profit as research and development spending falls.

   nasdaq.comNov 6, 2026 16:58 UTC
2. ▲ Bullish

   Moderna is raising its revenue forecast for 2026.

   valor.globo.comNov 6, 2026 16:18 UTCHigh importance
3. ▲ Bullish

   Moderna raised its full-year revenue growth outlook

   nasdaq.comNov 6, 2026 13:50 UTCHigh importance
4. ▲ Bullish

   Moderna reported a small profit in its first profitable quarter in two years

   endpoints.newsNov 6, 2026 13:02 UTC
5. ▲ Bullish

   Moderna raises 2026 revenue guidance to 15% to 25% growth

   cnbc.comNov 6, 2026 12:43 UTCHigh importance
6. ▲ Bullish

   Moderna has lifted its revenue growth outlook from up to 10% to 15% to 25%.

   wsj.comNov 6, 2026 12:39 UTCHigh importance
7. ▲ Bullish

   Moderna raised its 2026 guidance

   breakingthenews.netNov 6, 2026 12:11 UTCHigh importance
8. ▲ Bullish

   Moderna increased its revenue guidance for Covid vaccine sales

   bloomberg.comNov 6, 2026 11:45 UTC